Sign in
8-K

Current Report

Seres Therapeutics, Inc. Filed Acc 0001193125-24-045328

Executive or director change · Regulation FD disclosure

  • Item 5.02 Departure or appointment of directors or officers
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d784620d8k.htm…